The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Portrait of Shai Mulinari. Private image.

Shai Mulinari

Associate Professor | Senior Lecturer

Portrait of Shai Mulinari. Private image.

Unknowns of drug company payment disclosure : why the UK needs payment transparency legislation

Author

  • Piotr Ozieranski
  • Emily Rickard
  • Shai Mulinari

Summary, in English

New government legislation is necessary to ensure full transparency of industry payments in the UK’s healthcare. A first step should involve challenging the industry-­ driven discourse that allows company payment disclosures to be inconsequential for managing conflicts of interest.

Department/s

  • Sociology

Publishing year

2026

Language

English

Pages

7-12

Publication/Series

BMJ Evidence-Based Medicine

Volume

31

Issue

1

Document type

Article

Publisher

BMJ Publishing Group

Topic

  • Sociology (excluding Social Work, Social Anthropology, Demography and Criminology)
  • Health Care Service and Management, Health Policy and Services and Health Economy

Keywords

  • SDG 3 - Good Health and Well-being

Status

Published

Project

  • Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations

ISBN/ISSN/Other

  • ISSN: 2515-446X